Cydan is an orphan drug accelerator that identifies and de-risks programs with therapeutic and commercial potential. Cydan focuses on selecting promising assets with well-understood biology and proof-of-concept data in in vivo models from academia, industry and other sources. Data generated during a rigorous de-risking process enables formation of stand-alone companies and strategic partnerships.

Biotechnology

Education

Cydan

Chris Adams

ShiYin Foo

Ryan Tyler

Edward Calamai

Imran Babar

Laura Alessio

Leadership Team

Clinical Operations

Teams at Cydan

Leadership Team

Clinical Operations